Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Oral Diabetes Medicine Market Research Report 2024

Global Oral Diabetes Medicine Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 93 Pages

Report ld: 2128429

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Oral Diabetes Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oral Diabetes Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Diabetes Medicine.

Report Scope
The Oral Diabetes Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Diabetes Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Diabetes Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Oral Diabetes Medicine Market Research Report 2024
Global Oral Diabetes Medicine Companies Covered
Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda, AstraZeneca, Huadong Medicine, Eli Lilly and Company, Deyuan Pharmaceutical, Hengrui Medicine
Global Oral Diabetes Medicine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Diabetes Medicine Market, Segment by Type
DPP-4

GLP-1

SGLT-2
Global Oral Diabetes Medicine Market, Segment by Application
Type 1 Diabetes

Type 2 Diabetes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Diabetes Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Diabetes Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Oral Diabetes Medicine Market Overview
    1.1 Product Overview and Scope of Oral Diabetes Medicine
    1.2 Oral Diabetes Medicine Segment by Type
        1.2.1 Global Oral Diabetes Medicine Market Value Comparison by Type (2024-2030)
        1.2.2 DPP-4
        1.2.3 GLP-1
        1.2.4 SGLT-2
    1.3 Oral Diabetes Medicine Segment by Application
        1.3.1 Global Oral Diabetes Medicine Market Value by Application: (2024-2030)
        1.3.2 Type 1 Diabetes
        1.3.3 Type 2 Diabetes
    1.4 Global Oral Diabetes Medicine Market Size Estimates and Forecasts
        1.4.1 Global Oral Diabetes Medicine Revenue 2019-2030
        1.4.2 Global Oral Diabetes Medicine Sales 2019-2030
        1.4.3 Global Oral Diabetes Medicine Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Oral Diabetes Medicine Market Competition by Manufacturers
    2.1 Global Oral Diabetes Medicine Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Oral Diabetes Medicine Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Oral Diabetes Medicine Average Price by Manufacturers (2019-2024)
    2.4 Global Oral Diabetes Medicine Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Oral Diabetes Medicine, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Oral Diabetes Medicine, Product Type & Application
    2.7 Oral Diabetes Medicine Market Competitive Situation and Trends
        2.7.1 Oral Diabetes Medicine Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Oral Diabetes Medicine Players Market Share by Revenue
        2.7.3 Global Oral Diabetes Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Oral Diabetes Medicine Retrospective Market Scenario by Region
    3.1 Global Oral Diabetes Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Oral Diabetes Medicine Global Oral Diabetes Medicine Sales by Region: 2019-2030
        3.2.1 Global Oral Diabetes Medicine Sales by Region: 2019-2024
        3.2.2 Global Oral Diabetes Medicine Sales by Region: 2025-2030
    3.3 Global Oral Diabetes Medicine Global Oral Diabetes Medicine Revenue by Region: 2019-2030
        3.3.1 Global Oral Diabetes Medicine Revenue by Region: 2019-2024
        3.3.2 Global Oral Diabetes Medicine Revenue by Region: 2025-2030
    3.4 North America Oral Diabetes Medicine Market Facts & Figures by Country
        3.4.1 North America Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Oral Diabetes Medicine Sales by Country (2019-2030)
        3.4.3 North America Oral Diabetes Medicine Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Oral Diabetes Medicine Market Facts & Figures by Country
        3.5.1 Europe Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Oral Diabetes Medicine Sales by Country (2019-2030)
        3.5.3 Europe Oral Diabetes Medicine Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Oral Diabetes Medicine Market Facts & Figures by Country
        3.6.1 Asia Pacific Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Oral Diabetes Medicine Sales by Country (2019-2030)
        3.6.3 Asia Pacific Oral Diabetes Medicine Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Oral Diabetes Medicine Market Facts & Figures by Country
        3.7.1 Latin America Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Oral Diabetes Medicine Sales by Country (2019-2030)
        3.7.3 Latin America Oral Diabetes Medicine Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Oral Diabetes Medicine Market Facts & Figures by Country
        3.8.1 Middle East and Africa Oral Diabetes Medicine Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Oral Diabetes Medicine Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Oral Diabetes Medicine Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Oral Diabetes Medicine Sales by Type (2019-2030)
        4.1.1 Global Oral Diabetes Medicine Sales by Type (2019-2024)
        4.1.2 Global Oral Diabetes Medicine Sales by Type (2025-2030)
        4.1.3 Global Oral Diabetes Medicine Sales Market Share by Type (2019-2030)
    4.2 Global Oral Diabetes Medicine Revenue by Type (2019-2030)
        4.2.1 Global Oral Diabetes Medicine Revenue by Type (2019-2024)
        4.2.2 Global Oral Diabetes Medicine Revenue by Type (2025-2030)
        4.2.3 Global Oral Diabetes Medicine Revenue Market Share by Type (2019-2030)
    4.3 Global Oral Diabetes Medicine Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Oral Diabetes Medicine Sales by Application (2019-2030)
        5.1.1 Global Oral Diabetes Medicine Sales by Application (2019-2024)
        5.1.2 Global Oral Diabetes Medicine Sales by Application (2025-2030)
        5.1.3 Global Oral Diabetes Medicine Sales Market Share by Application (2019-2030)
    5.2 Global Oral Diabetes Medicine Revenue by Application (2019-2030)
        5.2.1 Global Oral Diabetes Medicine Revenue by Application (2019-2024)
        5.2.2 Global Oral Diabetes Medicine Revenue by Application (2025-2030)
        5.2.3 Global Oral Diabetes Medicine Revenue Market Share by Application (2019-2030)
    5.3 Global Oral Diabetes Medicine Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Sanofi Oral Diabetes Medicine Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 Biocon
        6.2.1 Biocon Corporation Information
        6.2.2 Biocon Description and Business Overview
        6.2.3 Biocon Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Biocon Oral Diabetes Medicine Product Portfolio
        6.2.5 Biocon Recent Developments/Updates
    6.3 Boehringer Ingelheim
        6.3.1 Boehringer Ingelheim Corporation Information
        6.3.2 Boehringer Ingelheim Description and Business Overview
        6.3.3 Boehringer Ingelheim Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Boehringer Ingelheim Oral Diabetes Medicine Product Portfolio
        6.3.5 Boehringer Ingelheim Recent Developments/Updates
    6.4 Merck & Co.
        6.4.1 Merck & Co. Corporation Information
        6.4.2 Merck & Co. Description and Business Overview
        6.4.3 Merck & Co. Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Merck & Co. Oral Diabetes Medicine Product Portfolio
        6.4.5 Merck & Co. Recent Developments/Updates
    6.5 Johnson & Johnson
        6.5.1 Johnson & Johnson Corporation Information
        6.5.2 Johnson & Johnson Description and Business Overview
        6.5.3 Johnson & Johnson Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Johnson & Johnson Oral Diabetes Medicine Product Portfolio
        6.5.5 Johnson & Johnson Recent Developments/Updates
    6.6 Novartis
        6.6.1 Novartis Corporation Information
        6.6.2 Novartis Description and Business Overview
        6.6.3 Novartis Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Novartis Oral Diabetes Medicine Product Portfolio
        6.6.5 Novartis Recent Developments/Updates
    6.7 Novo Nordisk
        6.6.1 Novo Nordisk Corporation Information
        6.6.2 Novo Nordisk Description and Business Overview
        6.6.3 Novo Nordisk Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Novo Nordisk Oral Diabetes Medicine Product Portfolio
        6.7.5 Novo Nordisk Recent Developments/Updates
    6.8 Takeda
        6.8.1 Takeda Corporation Information
        6.8.2 Takeda Description and Business Overview
        6.8.3 Takeda Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Takeda Oral Diabetes Medicine Product Portfolio
        6.8.5 Takeda Recent Developments/Updates
    6.9 AstraZeneca
        6.9.1 AstraZeneca Corporation Information
        6.9.2 AstraZeneca Description and Business Overview
        6.9.3 AstraZeneca Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 AstraZeneca Oral Diabetes Medicine Product Portfolio
        6.9.5 AstraZeneca Recent Developments/Updates
    6.10 Huadong Medicine
        6.10.1 Huadong Medicine Corporation Information
        6.10.2 Huadong Medicine Description and Business Overview
        6.10.3 Huadong Medicine Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 Huadong Medicine Oral Diabetes Medicine Product Portfolio
        6.10.5 Huadong Medicine Recent Developments/Updates
    6.11 Eli Lilly and Company
        6.11.1 Eli Lilly and Company Corporation Information
        6.11.2 Eli Lilly and Company Oral Diabetes Medicine Description and Business Overview
        6.11.3 Eli Lilly and Company Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 Eli Lilly and Company Oral Diabetes Medicine Product Portfolio
        6.11.5 Eli Lilly and Company Recent Developments/Updates
    6.12 Deyuan Pharmaceutical
        6.12.1 Deyuan Pharmaceutical Corporation Information
        6.12.2 Deyuan Pharmaceutical Oral Diabetes Medicine Description and Business Overview
        6.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.12.4 Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolio
        6.12.5 Deyuan Pharmaceutical Recent Developments/Updates
    6.13 Hengrui Medicine
        6.13.1 Hengrui Medicine Corporation Information
        6.13.2 Hengrui Medicine Oral Diabetes Medicine Description and Business Overview
        6.13.3 Hengrui Medicine Oral Diabetes Medicine Sales, Revenue and Gross Margin (2019-2024)
        6.13.4 Hengrui Medicine Oral Diabetes Medicine Product Portfolio
        6.13.5 Hengrui Medicine Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Oral Diabetes Medicine Industry Chain Analysis
    7.2 Oral Diabetes Medicine Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Oral Diabetes Medicine Production Mode & Process
    7.4 Oral Diabetes Medicine Sales and Marketing
        7.4.1 Oral Diabetes Medicine Sales Channels
        7.4.2 Oral Diabetes Medicine Distributors
    7.5 Oral Diabetes Medicine Customers

 8 Oral Diabetes Medicine Market Dynamics
    8.1 Oral Diabetes Medicine Industry Trends
    8.2 Oral Diabetes Medicine Market Drivers
    8.3 Oral Diabetes Medicine Market Challenges
    8.4 Oral Diabetes Medicine Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Diabetes Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Oral Diabetes Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Oral Diabetes Medicine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Oral Diabetes Medicine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Oral Diabetes Medicine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Oral Diabetes Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Oral Diabetes Medicine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Oral Diabetes Medicine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Oral Diabetes Medicine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Oral Diabetes Medicine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Oral Diabetes Medicine, Product Type & Application
    Table 12. Global Key Manufacturers of Oral Diabetes Medicine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oral Diabetes Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Diabetes Medicine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oral Diabetes Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Oral Diabetes Medicine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Oral Diabetes Medicine Sales Market Share by Region (2019-2024)
    Table 19. Global Oral Diabetes Medicine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Oral Diabetes Medicine Sales Market Share by Region (2025-2030)
    Table 21. Global Oral Diabetes Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Oral Diabetes Medicine Revenue Market Share by Region (2019-2024)
    Table 23. Global Oral Diabetes Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Oral Diabetes Medicine Revenue Market Share by Region (2025-2030)
    Table 25. North America Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Oral Diabetes Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Oral Diabetes Medicine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Oral Diabetes Medicine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Oral Diabetes Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Oral Diabetes Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Oral Diabetes Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Oral Diabetes Medicine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Oral Diabetes Medicine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Oral Diabetes Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Oral Diabetes Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Oral Diabetes Medicine Sales (K Units) by Type (2019-2024)
    Table 51. Global Oral Diabetes Medicine Sales (K Units) by Type (2025-2030)
    Table 52. Global Oral Diabetes Medicine Sales Market Share by Type (2019-2024)
    Table 53. Global Oral Diabetes Medicine Sales Market Share by Type (2025-2030)
    Table 54. Global Oral Diabetes Medicine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Oral Diabetes Medicine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Oral Diabetes Medicine Revenue Market Share by Type (2019-2024)
    Table 57. Global Oral Diabetes Medicine Revenue Market Share by Type (2025-2030)
    Table 58. Global Oral Diabetes Medicine Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Oral Diabetes Medicine Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Oral Diabetes Medicine Sales (K Units) by Application (2019-2024)
    Table 61. Global Oral Diabetes Medicine Sales (K Units) by Application (2025-2030)
    Table 62. Global Oral Diabetes Medicine Sales Market Share by Application (2019-2024)
    Table 63. Global Oral Diabetes Medicine Sales Market Share by Application (2025-2030)
    Table 64. Global Oral Diabetes Medicine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Oral Diabetes Medicine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Oral Diabetes Medicine Revenue Market Share by Application (2019-2024)
    Table 67. Global Oral Diabetes Medicine Revenue Market Share by Application (2025-2030)
    Table 68. Global Oral Diabetes Medicine Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Oral Diabetes Medicine Price (US$/Unit) by Application (2025-2030)
    Table 70. Sanofi Corporation Information
    Table 71. Sanofi Description and Business Overview
    Table 72. Sanofi Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Sanofi Oral Diabetes Medicine Product
    Table 74. Sanofi Recent Developments/Updates
    Table 75. Biocon Corporation Information
    Table 76. Biocon Description and Business Overview
    Table 77. Biocon Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Biocon Oral Diabetes Medicine Product
    Table 79. Biocon Recent Developments/Updates
    Table 80. Boehringer Ingelheim Corporation Information
    Table 81. Boehringer Ingelheim Description and Business Overview
    Table 82. Boehringer Ingelheim Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Boehringer Ingelheim Oral Diabetes Medicine Product
    Table 84. Boehringer Ingelheim Recent Developments/Updates
    Table 85. Merck & Co. Corporation Information
    Table 86. Merck & Co. Description and Business Overview
    Table 87. Merck & Co. Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Merck & Co. Oral Diabetes Medicine Product
    Table 89. Merck & Co. Recent Developments/Updates
    Table 90. Johnson & Johnson Corporation Information
    Table 91. Johnson & Johnson Description and Business Overview
    Table 92. Johnson & Johnson Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Johnson & Johnson Oral Diabetes Medicine Product
    Table 94. Johnson & Johnson Recent Developments/Updates
    Table 95. Novartis Corporation Information
    Table 96. Novartis Description and Business Overview
    Table 97. Novartis Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Novartis Oral Diabetes Medicine Product
    Table 99. Novartis Recent Developments/Updates
    Table 100. Novo Nordisk Corporation Information
    Table 101. Novo Nordisk Description and Business Overview
    Table 102. Novo Nordisk Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Novo Nordisk Oral Diabetes Medicine Product
    Table 104. Novo Nordisk Recent Developments/Updates
    Table 105. Takeda Corporation Information
    Table 106. Takeda Description and Business Overview
    Table 107. Takeda Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Takeda Oral Diabetes Medicine Product
    Table 109. Takeda Recent Developments/Updates
    Table 110. AstraZeneca Corporation Information
    Table 111. AstraZeneca Description and Business Overview
    Table 112. AstraZeneca Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. AstraZeneca Oral Diabetes Medicine Product
    Table 114. AstraZeneca Recent Developments/Updates
    Table 115. Huadong Medicine Corporation Information
    Table 116. Huadong Medicine Description and Business Overview
    Table 117. Huadong Medicine Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Huadong Medicine Oral Diabetes Medicine Product
    Table 119. Huadong Medicine Recent Developments/Updates
    Table 120. Eli Lilly and Company Corporation Information
    Table 121. Eli Lilly and Company Description and Business Overview
    Table 122. Eli Lilly and Company Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Eli Lilly and Company Oral Diabetes Medicine Product
    Table 124. Eli Lilly and Company Recent Developments/Updates
    Table 125. Deyuan Pharmaceutical Corporation Information
    Table 126. Deyuan Pharmaceutical Description and Business Overview
    Table 127. Deyuan Pharmaceutical Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Deyuan Pharmaceutical Oral Diabetes Medicine Product
    Table 129. Deyuan Pharmaceutical Recent Developments/Updates
    Table 130. Hengrui Medicine Corporation Information
    Table 131. Hengrui Medicine Description and Business Overview
    Table 132. Hengrui Medicine Oral Diabetes Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Hengrui Medicine Oral Diabetes Medicine Product
    Table 134. Hengrui Medicine Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Oral Diabetes Medicine Distributors List
    Table 138. Oral Diabetes Medicine Customers List
    Table 139. Oral Diabetes Medicine Market Trends
    Table 140. Oral Diabetes Medicine Market Drivers
    Table 141. Oral Diabetes Medicine Market Challenges
    Table 142. Oral Diabetes Medicine Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Oral Diabetes Medicine
    Figure 2. Global Oral Diabetes Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Oral Diabetes Medicine Market Share by Type in 2023 & 2030
    Figure 4. DPP-4 Product Picture
    Figure 5. GLP-1 Product Picture
    Figure 6. SGLT-2 Product Picture
    Figure 7. Global Oral Diabetes Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Oral Diabetes Medicine Market Share by Application in 2023 & 2030
    Figure 9. Type 1 Diabetes
    Figure 10. Type 2 Diabetes
    Figure 11. Global Oral Diabetes Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Oral Diabetes Medicine Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Oral Diabetes Medicine Sales (2019-2030) & (K Units)
    Figure 14. Global Oral Diabetes Medicine Average Price (US$/Unit) & (2019-2030)
    Figure 15. Oral Diabetes Medicine Report Years Considered
    Figure 16. Oral Diabetes Medicine Sales Share by Manufacturers in 2023
    Figure 17. Global Oral Diabetes Medicine Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Oral Diabetes Medicine Players: Market Share by Revenue in 2023
    Figure 19. Oral Diabetes Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Oral Diabetes Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Oral Diabetes Medicine Sales Market Share by Country (2019-2030)
    Figure 22. North America Oral Diabetes Medicine Revenue Market Share by Country (2019-2030)
    Figure 23. United States Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Oral Diabetes Medicine Sales Market Share by Country (2019-2030)
    Figure 26. Europe Oral Diabetes Medicine Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Oral Diabetes Medicine Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Oral Diabetes Medicine Revenue Market Share by Region (2019-2030)
    Figure 34. China Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Southeast Asia Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Latin America Oral Diabetes Medicine Sales Market Share by Country (2019-2030)
    Figure 42. Latin America Oral Diabetes Medicine Revenue Market Share by Country (2019-2030)
    Figure 43. Mexico Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Brazil Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Argentina Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Country (2019-2030)
    Figure 47. Middle East & Africa Oral Diabetes Medicine Revenue Market Share by Country (2019-2030)
    Figure 48. Turkey Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. UAE Oral Diabetes Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Global Sales Market Share of Oral Diabetes Medicine by Type (2019-2030)
    Figure 52. Global Revenue Market Share of Oral Diabetes Medicine by Type (2019-2030)
    Figure 53. Global Oral Diabetes Medicine Price (US$/Unit) by Type (2019-2030)
    Figure 54. Global Sales Market Share of Oral Diabetes Medicine by Application (2019-2030)
    Figure 55. Global Revenue Market Share of Oral Diabetes Medicine by Application (2019-2030)
    Figure 56. Global Oral Diabetes Medicine Price (US$/Unit) by Application (2019-2030)
    Figure 57. Oral Diabetes Medicine Value Chain
    Figure 58. Oral Diabetes Medicine Production Process
    Figure 59. Channels of Distribution (Direct Vs Distribution)
    Figure 60. Distributors Profiles
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Description

The global Oral Diabetes Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Diabetes Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation